We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$81B
AUM Growth
-$1.58B
Cap. Flow
-$3.65B
Cap. Flow %
-4.5%
Top 10 Hldgs %
16.13%
Holding
1,955
New
98
Increased
953
Reduced
772
Closed
100

Top Sells

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$786M
2
ABEV icon
Ambev
ABEV
+$368M
3
AAPL icon
Apple
AAPL
+$331M
4
BIDU icon
Baidu
BIDU
+$323M
5
JNJ icon
Johnson & Johnson
JNJ
+$285M

Sector Composition

Rank Sector Weight
1 Energy 15.38%
2 Financials 14.63%
3 Consumer Discretionary 13.36%
4 Healthcare 12.27%
5 Technology 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFC icon
826
Truist Financial
TFC
$63.2B
$4.6M 0.01%
101,258
+12,340
+14% +$536K
PBI icon
827
Pitney Bowes
PBI
$2.42B
$4.58M 0.01%
303,087
-58,797
-16% -$859K
AKS
828
DELISTED
AK Steel Holding Corp
AKS
$4.56M 0.01%
693,638
+166,796
+32% +$1.05M
IRM icon
829
Iron Mountain
IRM
$38.2B
$4.54M 0.01%
132,162
+315
+0.2% +$11K
CF icon
830
CF Industries
CF
$19.2B
$4.54M 0.01%
162,247
-2,437
-1% -$67.1K
REVG
831
DELISTED
REV Group
REVG
$4.51M 0.01%
162,810
+15,150
+10% +$422K
OVID icon
832
Ovid Therapeutics
OVID
$435M
$4.46M 0.01%
+425,000
New +$5.55M
SNX icon
833
TD Synnex
SNX
$19.4B
$4.42M 0.01%
73,778
+2,652
+4% +$148K
COF icon
834
Capital One
COF
$124B
$4.42M 0.01%
53,455
+7,523
+16% +$611K
HPE icon
835
Hewlett Packard
HPE
$63.2B
$4.3M 0.01%
334,351
-144,606
-30% -$2.01M
MCY icon
836
Mercury Insurance
MCY
$5.94B
$4.29M 0.01%
79,384
+3,209
+4% +$182K
TRV icon
837
Travelers Companies
TRV
$80.8B
$4.18M 0.01%
33,036
+230
+0.7% +$28.3K
NSIT icon
838
Insight Enterprises
NSIT
$3.55B
$4.08M 0.01%
101,962
+7,771
+8% +$328K
ABM icon
839
ABM Industries
ABM
$2.8B
$3.93M ﹤0.01%
94,583
-503,070
-84% -$21.3M
KELYA icon
840
Kelly Services Class A
KELYA
$526M
$3.87M ﹤0.01%
172,507
-8,275
-5% -$185K
BTU icon
841
Peabody Energy
BTU
$2.78B
$3.83M ﹤0.01%
+156,596
New +$3.87M
MGLN
842
DELISTED
Magellan Health Services, Inc.
MGLN
$3.79M ﹤0.01%
52,045
-942
-2% -$66.2K
ESND
843
DELISTED
Essendant Inc.
ESND
$3.7M ﹤0.01%
249,557
-15,823
-6% -$250K
DXCM icon
844
DexCom
DXCM
$27.6B
$3.66M ﹤0.01%
200,160
-208,400
-51% -$3.85M
AZN icon
845
AstraZeneca
AZN
$263B
$3.63M ﹤0.01%
+53,185
New +$3.47M
GEO icon
846
The GEO Group
GEO
$4.13B
$3.55M ﹤0.01%
120,047
-799,384
-87% -$25.1M
SEM
847
DELISTED
Select Medical
SEM
$3.47M ﹤0.01%
419,076
-46,813
-10% -$351K
AFL icon
848
Aflac
AFL
$63.9B
$3.44M ﹤0.01%
88,504
-2,796
-3% -$105K
MUX icon
849
McEwen Inc
MUX
$1.03B
$3.44M ﹤0.01%
130,686
ASM
850
Avino Silver & Gold Mines
ASM
$987M
$3.36M ﹤0.01%
2,097,200
+750,000
+56% +$1.19M

Similar funds

OppenheimerFunds's Q2 2017 Portfolio in Review

As of Q2 2017, OppenheimerFunds held 1,955 positions worth $81B, down 1.9% from $82.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

OppenheimerFunds withdrew a net $3.65B in Q2 2017, closing 100 positions and reducing 772 holdings. Its most notable exit was Energy Transfer Partners L.p., an estimated $786M position sold in full.

By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, OppenheimerFunds opened a new position in Antero Midstream worth $132M.

  • OppenheimerFunds's largest Q2 2017 buy was Antero Midstream: 5,990,120 shares worth $132M.
  • OppenheimerFunds added most to Energy Transfer Partners, L.P. in Q2 2017, an estimated $729M increase.
  • OppenheimerFunds's biggest Q2 2017 reduction was Apple, cutting an estimated $331M.
  • OppenheimerFunds fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $786M.
  • OppenheimerFunds's ten largest holdings make up 16% of its $81B portfolio in Q2 2017.
  • OppenheimerFunds opened 98 new positions and closed 100 in Q2 2017.
  • OppenheimerFunds's portfolio value fell 1.9% quarter-over-quarter to $81B.

Based on OppenheimerFunds's 13F filing for Q2 2017, filed 14 Aug 2017.